Patients with systemic lupus erythematosus (SLE) and type 2 diabetes, with and without lupus nephritis (LN), had a lower risk ...

A new Northwestern Medicine study has shed light on how a class of diabetes drugs may protect the kidneys—not just by ...

Dr Shivani Misra is a clinical associate professor and honorary consultant in diabetes at Imperial College London ...

Mounjaro and Ozempic are two different drugs to manage type 2 diabetes and weight loss. Know all about their benefits and likely side effects.

A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian ...

Type 2 diabetes medications, such as sulfonylureas, have been a mainstay of treating the disease since they came on the ...

Obesity treatment is hurtling into a new era: once-a-week GLP-1 injections are edging toward the dramatic results of ...

India embraces GLP-1 medications as a major advance in diabetes and obesity care. Experts warn these drugs require medical ...

Novo Nordisk’s weekly injection for type 2 diabetes, Ozempic, is set to launch in India. Here’s how it works, its benefits, ...

Medical experts recognize type 5 diabetes as separate from other types, requiring specialized treatment focusing on ...

In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial reported that a daily pill of ...

Two studies associate GLP-1 drugs, such as semaglutide and tirzepatide, with eye health issues and vision problems in some ...